Cargando…
Equibalancing immune‐related adverse events and anticancer activity of immune checkpoint inhibitors
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons Australia, Ltd
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775024/ https://www.ncbi.nlm.nih.gov/pubmed/31456312 http://dx.doi.org/10.1111/1759-7714.13180 |
| _version_ | 1783456146646892544 |
|---|---|
| author | Seeruttun, Sharvesh Raj |
| author_facet | Seeruttun, Sharvesh Raj |
| author_sort | Seeruttun, Sharvesh Raj |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6775024 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | John Wiley & Sons Australia, Ltd |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-67750242019-10-07 Equibalancing immune‐related adverse events and anticancer activity of immune checkpoint inhibitors Seeruttun, Sharvesh Raj Thorac Cancer Editorial John Wiley & Sons Australia, Ltd 2019-08-28 2019-10 /pmc/articles/PMC6775024/ /pubmed/31456312 http://dx.doi.org/10.1111/1759-7714.13180 Text en © 2019 The Author. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Editorial Seeruttun, Sharvesh Raj Equibalancing immune‐related adverse events and anticancer activity of immune checkpoint inhibitors |
| title | Equibalancing immune‐related adverse events and anticancer activity of immune checkpoint inhibitors |
| title_full | Equibalancing immune‐related adverse events and anticancer activity of immune checkpoint inhibitors |
| title_fullStr | Equibalancing immune‐related adverse events and anticancer activity of immune checkpoint inhibitors |
| title_full_unstemmed | Equibalancing immune‐related adverse events and anticancer activity of immune checkpoint inhibitors |
| title_short | Equibalancing immune‐related adverse events and anticancer activity of immune checkpoint inhibitors |
| title_sort | equibalancing immune‐related adverse events and anticancer activity of immune checkpoint inhibitors |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775024/ https://www.ncbi.nlm.nih.gov/pubmed/31456312 http://dx.doi.org/10.1111/1759-7714.13180 |
| work_keys_str_mv | AT seeruttunsharveshraj equibalancingimmunerelatedadverseeventsandanticanceractivityofimmunecheckpointinhibitors |